Turning Concepts Into Products

The core of the JAKK Group's strategy is the application of EXISTING technology to provide solutions to unmet clinical needs. This substantially reduces the time and cost of early development. The JAKK Group also ensures the opportunity is synergistic with the business of major medical companies, most importantly in the area of sales force and physician call point. This immediately aligns our objectives with potential partners and acquirers and can help provide more resources, opportunity validation, and a pathway to exit. A summary of our screening process to identify valuable opportunities is summarized below:

1. Identify unmet clinical needs, preferably in therapeutic areas;
2. Identify areas that are synergistic with potential partners or acquirers of our products in terms of sales force, business strategy, or technology infrastructure;
3. Identify therapy solutions focusing on the application of EXISTING technologies;
4. Identify and assess the strength of the intellectual property position.